Stereotaxis CEO David Fischel says the MAGiC catheter was designed "to overcome the natural limitations of manual pull-wire ...
Stereotaxis has won FDA approval for the MAGiC Magnetic Interventional Ablation Catheter. The device is a robotically ...
Please provide your email address to receive an email when new articles are posted on . The FDA approved a mapping and dual-energy catheter ablation system for treatment of persistent AF. The system ...
TipRanks on MSN
Boston Scientific’s global pulsed field ablation trial targets persistent atrial fibrillation growth
Boston Scientific ($BSX) announced an update on their ongoing clinical study. Study OverviewThis global Boston Scientific trial, officially titled ...
Only a few months after Medtronic completed its acquisition of cardiac device maker Affera, the nearly billion-dollar buyout is already paying off. A dual-use catheter originally developed by Affera ...
Other hot topics included new data on LAAO and conduction-system pacing, plus the go-ahead for ablation in ASCs.
LISBON — A lot of functionality has been packed into one balloon catheter for treating atrial fibrillation (AF). The multielectrode, radiofrequency (RF) balloon catheter with integrated mapping and ...
New FARAWAVE™ NAV Ablation Catheter and FARAVIEW™ Software combine with OPAL HDx™ Mapping System to provide visualization during pulsed field ablation MARLBOROUGH, Mass., Oct. 18, 2024 /PRNewswire/ -- ...
First-of-its-kind, all-in-one HD-mapping and dual energy (pulsed field and radiofrequency) ablation catheter Highly anticipated by electrophysiologists for its innovation and demonstrated safety and ...
After claiming its approval in Europe earlier this year, Abbott has secured the FDA’s go-ahead for its Volt pulsed field ablation system for irregular heart rhythms, a step forward in an | With the U.
There is an indisputable trend toward minimally invasive, outpatient procedures in healthcare. Outpatient procedures help to alleviate burdens on the healthcare system, save patients time, money, and ...
Stereotaxis plans to launch the MAGiC cardiac ablation catheter in early 2026, CEO and Chair David Fischel tells MassDevice.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback